Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,957,413 | $1,920,870 | $3,260,439 | $2,453,145 |
| - Cash | $453,001 | $311,660 | $243,784 | $234,309 |
| + Debt | $181,406 | $193,566 | $191,647 | $195,744 |
| Enterprise Value | $1,685,818 | $1,802,776 | $3,208,302 | $2,414,580 |
| Revenue | $714,734 | $582,022 | $437,855 | $305,440 |
| % Growth | 22.8% | 32.9% | 43.4% | – |
| Gross Profit | $557,919 | $460,786 | $354,374 | $249,922 |
| % Margin | 78.1% | 79.2% | 80.9% | 81.8% |
| EBITDA | $233,412 | $221,512 | $146,866 | $80,462 |
| % Margin | 32.7% | 38.1% | 33.5% | 26.3% |
| Net Income | $145,493 | $128,853 | $181,468 | $34,597 |
| % Margin | 20.4% | 22.1% | 41.4% | 11.3% |
| EPS Diluted | 2.51 | 2.13 | 2.97 | 0.58 |
| % Growth | 17.8% | -28.3% | 412.1% | – |
| Operating Cash Flow | $219,821 | $219,387 | $144,466 | $98,557 |
| Capital Expenditures | -$1,153 | -$312 | -$172 | -$298 |
| Free Cash Flow | $218,668 | $219,075 | $144,294 | $98,259 |